FDA Permits Marketing Of First Device To Prevent Migraines
The FDA decision was made based on safety and effectiveness data from 67 people, as well as patient satisfaction data from
fda permits marketing device prevent migraines fda decision base safety effectiveness datum people patient satisfaction datum